Benzinga | May 25, 2021 06:42AM EDT

Barclays Initiates Coverage On Insulet with Overweight Rating, Announces Price Target of $300

Barclays analyst Travis Steed initiates coverage on Insulet (NASDAQ:PODD) with a Overweight rating and announces Price Target of $300.